Qualitative and Quantitative Detection of PrPSc Based on the Controlled Release Property of Magnetic Microspheres Using Surface Plasmon Resonance (SPR)

• Published in: Nanomaterials (Basel, Switzerland) Vol. 8; no. 2; p. 107
• Main Authors: Lou, Zhichao, Han, He, Mao, Dun, Jiang, Yibin, Song, Jianyue
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 13.02.2018; MDPI
• Subjects: aptamer 3; Aptamers; Biomolecules; Biosensors; Chemical bonds; Controlled release; Disinfection & disinfectants; Embedding; Free radicals; Gold; Infections; Magnetic fields; magnetic microsphere 4; Magnetic properties; Magnetic resonance; Microspheres; Nanomaterials; Nanoparticles; Nanotechnology; Prion protein; prion protein 2; Proteins; Radiation; Reagents; Resonance; self-assembling 5; sensitive 6; Sensitivity; Surface plasmon resonance; surface plasmon resonance 1
• ISSN: 2079-4991; 2079-4991
• DOI: 10.3390/nano8020107

Prion protein (PrPSc) has drawn widespread attention due to its pathological potential to prion diseases. In this work, we constructed a novel surface plasmon resonance (SPR) detection assay involving magnetic microspheres (MMs) and its controlled release property, for selective capture, embedding, concentration, and SPR detection of PrPSc with high sensitivity and specificity. Aptamer-modified magnetic particles (AMNPs) were used to specifically capture PrPSc. Amphiphilic copolymer was used to embed the labeled PrPSc and form magnetic microspheres to isolate PrPSc from the external environment. Static magnetic and alternating magnetic fields were used to concentrate and control release the embedded PrPSc, respectively. Finally, the released AMNPs-labeled PrPSc was detected by SPR which was equipped with a bare gold sensing film. A good linear relationship was obtained between SPR responses and the logarithm of PrPSc concentrations over a range of 0.01-1000 ng/mL. The detection sensitivity for PrPSc was improved by 10 fold compared with SPR direct detection format. The specificity of the present biosensor was also determined by PrPC and other reagents as controls. This proposed approach could also be used to isolate and detect other highly pathogenic biomolecules with similar structural characteristics by altering the corresponding aptamer in the AMNPs conjugates.